Credit: Horsham Township/facebook.com
Horsham Township welcomed its newest business into town in December.
ClinChoice, a global contract research organization (CRO) that accelerates drug and device approvals, held a ribbon-cutting ceremony on Dec. 15, 2024, along with Horsham Township officials at its facility in the Horsham Business Center, 300 Welsh Rd.
“We are thrilled to welcome the international headquarters of ClinChoice to Horsham Township,” Horsham Township posted on its Facebook page. “Our Township Manager Bill Gildea-Walker helped to welcome them by participating in their ribbon cutting. We are so happy they chose Horsham and we look forward to introducing them to our community.”
You can view a photo album from the grand opening, ribbon-cutting ceremony here.
Therapeutic areas that the company specializes in includes: autoimmune & inflammation, dermatology, endocrinology & metabolic, infectious disease, neuroscience, oncology & hematology, ophthalmology, respiratory, cardiovascular, gastrointestinal, musculoskeletal, nephrology & urology, and women’s health.
“This significant milestone underscores ClinChoice’s dedication to providing innovative and efficient solutions across the pharmaceutical, biotechnology, medical device, and natraceutical industries,” said Tim Draper. “The new headquarters will serve as a hub for supporting clients throughout product development lifecycle, from early clinical development to post-approval lifecycle management.”
ClinChoice has served six of the top 10 pharmaceutical companies and numerous innovators worldwide. The organization’s mission is to accelerate the development and commercialization of life changing therapies. The company established in 1995 and is a recognized global, full-service CRO specializing in clinical development, post-marketing, and functional service support.
The business is located in Suite 201, Building 5 in the Horsham Business Center. For more information, call (215) 283-6035.
The company has only one other location in the U.S. (North Carolina), and one in Canada.
